You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

 

Online download statistics by month:

Online download statistics by month: March 2017 to April 2023

AbstractFullPdf
Mar 20171291311175
Apr 2017583174133
May 2017346127121
Jun 20172014835
Jul 20173758051
Aug 20171346309166
Sep 20171155180119
Oct 20176289183
Nov 20174306948
Dec 20173464335
Jan 20184528167
Feb 20183835144
Mar 20183635232
Apr 20183206643
May 201840417992
Jun 2018154187
Jul 20181832217
Aug 20182093518
Sep 20182134424
Oct 20183256022
Nov 20182063323
Dec 2018128145
Jan 20191624117
Feb 20191972415
Mar 20192596039
Apr 20191222918
May 20192073818
Jun 2019117177
Jul 20192174522
Aug 20192672422
Sep 20192782316
Oct 20191582615
Nov 20191704016
Dec 2019149187
Jan 20201943020
Feb 2020201345
Mar 20202893619
Apr 20201503012
May 20201781318
Jun 20201322323
Jul 20201711613
Aug 20201402014
Sep 20202273116
Oct 20201533214
Nov 20202892723
Dec 2020148114
Jan 20212192117
Feb 20212762433
Mar 20212943127
Apr 20211883718
May 20211663017
Jun 2021362618
Jul 2021382312
Aug 202126129
Sep 2021452624
Oct 20212053315
Nov 20213114327
Dec 2021161156
Jan 2022261339
Feb 2022165185
Mar 20222854923
Apr 2022140299
May 2022307199
Jun 2022251306
Jul 2022240838
Aug 20222512614
Sep 2022146198
Oct 20222824917
Nov 2022243478
Dec 2022103323
Jan 20233177517
Feb 20232243017
Mar 2023131166
Apr 20231381811
Total2006536692146